 |
| August
28, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jason Cole, CEO and Board Member, Zag Bio,
Inc. |
In
this week’s CEO Q&A, Cole, who lives
with type 1 diabetes himself, discusses
the science behind Zag’s thymus-targeted
platform, what differentiates its approach
from other immune-tolerance strategies in
development, and his outlook for turning
immune tolerance from long-standing
scientific aspiration into real therapies
for patients. More
|
|
|
 |
|
One Partner For Your Entire
Vivarium. Research Ready From Day
One. |
|
Learn More
→ |
|
|
- Adicet Bio: FDA Clearance of IND Application
for ADI-212 More
- Cytokinetics: Positive Results From
ACACIA-HCM Presented in Hot Line Session at
the European Society of Cardiology (ESC)
Congress 2026 and Published in The New England
Journal of Medicine More
More
More*
- Gilead: U.S. FDA Approves Bixlenvo, a New
Once-Daily Single Tablet Option for
Virologically Suppressed Adults With HIV,
Including Those on Complex Regimens More
More
More*
More*
- UCSF: QBI Creates Largest Ever Molecular Map
of Autism, Opening New Paths to Precision
Therapies
More
More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- AusperBio: Completes $120 Million Series
C Financing to Advance AHB-137 Toward
Potential Commercialization and Expand
Next-Generation HBV Therapies More
- Genentech Doubles Down on ADC-Resistant
Cancers With $1B DualityBio Pact More
More*
- LSN: Hot Investor Mandates (Updated 8/25) More
- UCSF: Quantitative Biosciences Institute
Awarded $46 Million to Advance Groundbreaking
Autism Research More
More
|
|
- After Some ‘Tough Years,’ Frontier’s CEO Is
Ramping Up Ambitions for Precision Med
Platform More
- Big4Bio CEO Weekly Q&A: Jason
Cole, CEO and Board Member, Zag Bio, Inc.
More
- BioPharmGuy News: 2nd Place Finish, Sugar
Problems, Ghost Roast, Mummy Issues, Fruit
Buds More
- Biotech & Pharma Updates | August 27,
2026 More
- More on FDA Approving Rasonque, First in
Class Targeted Pancreatic Cancer Therapy More*
More
More
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
- Alto Neuroscience: Promotes Nick Smith to
President and Chief Financial Officer More
- OPPORTUNITY: Chief Operating Officer, Remote
More
- OPPORTUNITY: Computational Scientist, New
York More
- OPPORTUNITY: Head of
Computational Method Development, Boston
More
- Slone Partners: Fractional
Leadership in Biotech and Life Sciences -
When it Works and Why More
- Slone Partners: Places Farhad Ghavami as
Chief Executive Officer at SeqCenter More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
